Alexander Bellendorf1, Veria Khosrawipour2,3, Tanja Khosrawipour2,3, Simon Siebigteroth1, Joseph Cohnen1, David Diaz-Carballo4, Andreas Bockisch1, Jürgen Zieren3, Urs Giger-Pabst5,6. 1. Department of Nuclear Medicine, University Hospital Essen, Essen, Germany. 2. Basic Research Laboratory Department of Surgery, St. Mary's Hospital Herne, Ruhr University Bochum, Bochum, Germany. 3. Department of Surgery & Therapy Center for Peritonealcarcinomatosis, St. Mary's Hospital Herne, Ruhr University Bochum, Bochum, Germany. 4. Hematology & Medical Oncology, St. Mary's Hospital Herne, Ruhr University Bochum, Bochum, Germany. 5. Basic Research Laboratory Department of Surgery, St. Mary's Hospital Herne, Ruhr University Bochum, Bochum, Germany. urs.pabst@elisabethgruppe.de. 6. Department of Surgery & Therapy Center for Peritonealcarcinomatosis, St. Mary's Hospital Herne, Ruhr University Bochum, Bochum, Germany. urs.pabst@elisabethgruppe.de.
Abstract
BACKGROUND: Although recent data are contradictory, it is still claimed that Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) would deliver an aerosol which distributes homogeneously throughout the entire abdominal cavity. METHODS: 99mTc-Pertechnetat was administered in four postmortem swine using either PIPAC or liquid intra-peritoneal chemotherapy (IPC). The animals were examined by planar scintigraphy and SPECT/CT. Planar distribution images were divided into four regions of interest (ROIs: right/left upper and lower abdominal quadrant). SPECT/CT slices were scanned for areas of intense nuclide accumulation ("hot spots"). The percentage of relative distribution for planar scintigraphy was calculated by dividing the summed individual counts of each ROI by total counts measured in the entire abdominal cavity. The relative distribution of the "hot spots" was analyzed by dividing the counts of the local volume of interest (VOI) by the summed volume counts measured in the entire abdominal cavity. RESULTS: In all four animals, planar scintigraphy showed inhomogeneous nuclide distribution. After PIPAC only 8-10% of the delivered nuclide was detected in one ROI with a mean deviation of 40% and 74% from a uniform nuclide distribution pattern. In all animals, SPECT/CT revealed "hot spots" beneath the PIPAC Micropump, catheter tip, and in the cul-de-sac region which comprise about 25% of the total amount of delivered nuclide in 2.5% of the volume of the entire abdominal cavity. CONCLUSIONS: Our present data indicate that the intra-abdominal aerosol distribution pattern of PIPAC therapy is non-homogeneous and that the currently applied technology has still not overcome the problem of inhomogeneous drug distribution of IPC.
BACKGROUND: Although recent data are contradictory, it is still claimed that Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) would deliver an aerosol which distributes homogeneously throughout the entire abdominal cavity. METHODS: 99mTc-Pertechnetat was administered in four postmortem swine using either PIPAC or liquid intra-peritoneal chemotherapy (IPC). The animals were examined by planar scintigraphy and SPECT/CT. Planar distribution images were divided into four regions of interest (ROIs: right/left upper and lower abdominal quadrant). SPECT/CT slices were scanned for areas of intense nuclide accumulation ("hot spots"). The percentage of relative distribution for planar scintigraphy was calculated by dividing the summed individual counts of each ROI by total counts measured in the entire abdominal cavity. The relative distribution of the "hot spots" was analyzed by dividing the counts of the local volume of interest (VOI) by the summed volume counts measured in the entire abdominal cavity. RESULTS: In all four animals, planar scintigraphy showed inhomogeneous nuclide distribution. After PIPAC only 8-10% of the delivered nuclide was detected in one ROI with a mean deviation of 40% and 74% from a uniform nuclide distribution pattern. In all animals, SPECT/CT revealed "hot spots" beneath the PIPAC Micropump, catheter tip, and in the cul-de-sac region which comprise about 25% of the total amount of delivered nuclide in 2.5% of the volume of the entire abdominal cavity. CONCLUSIONS: Our present data indicate that the intra-abdominal aerosol distribution pattern of PIPAC therapy is non-homogeneous and that the currently applied technology has still not overcome the problem of inhomogeneous drug distribution of IPC.
Authors: Deborah K Armstrong; Brian Bundy; Lari Wenzel; Helen Q Huang; Rebecca Baergen; Shashikant Lele; Larry J Copeland; Joan L Walker; Robert A Burger Journal: N Engl J Med Date: 2006-01-05 Impact factor: 91.245
Authors: Philippe Esquis; David Consolo; Guy Magnin; Philippe Pointaire; Philippe Moretto; Maria Dolores Ynsa; Jean-Luc Beltramo; Carole Drogoul; Michel Simonet; Laurent Benoit; Patrick Rat; Bruno Chauffert Journal: Ann Surg Date: 2006-07 Impact factor: 12.969
Authors: Daniel Göhler; Veria Khosrawipour; Tanja Khosrawipour; David Diaz-Carballo; Thomas Albert Falkenstein; Jürgen Zieren; Michael Stintz; Urs Giger-Pabst Journal: Surg Endosc Date: 2016-09-08 Impact factor: 4.584
Authors: Olivier Facy; Sophie Al Samman; Guy Magnin; Francois Ghiringhelli; Sylvain Ladoire; Bruno Chauffert; Patrick Rat; Pablo Ortega-Deballon Journal: Ann Surg Date: 2012-12 Impact factor: 12.969
Authors: Wiebke Solass; Reinhold Kerb; Thomas Mürdter; Urs Giger-Pabst; Dirk Strumberg; Clemens Tempfer; Jürgen Zieren; Matthias Schwab; Marc André Reymond Journal: Ann Surg Oncol Date: 2013-09-05 Impact factor: 5.344
Authors: Rafael Seitenfus; Antonio Nocchi Kalil; Eduardo Dipp de Barros; Claudio Galeano Zettler; Gabriel Oliveira Dos Santos; Olivier Glehen; Carlos Humberto Cereser Junior; Paulo Roberto Walter Ferreira Journal: Surg Endosc Date: 2019-08-01 Impact factor: 4.584
Authors: Daniel Göhler; Stephan Große; Alexander Bellendorf; Thomas Albert Falkenstein; Mehdi Ouaissi; Jürgen Zieren; Michael Stintz; Urs Giger-Pabst Journal: Beilstein J Nanotechnol Date: 2017-12-18 Impact factor: 3.649